openPR Logo

Press Releases from 24/7QualityMeds (1 total)

Inavolisib: Tests That Matter

Targeted cancer therapies have transformed the management of advanced breast cancer by addressing specific molecular alterations that drive tumor growth. Inavolisib (Itovebi) is a selective

Go To Page: